PL3368046T3 - Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania - Google Patents

Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania

Info

Publication number
PL3368046T3
PL3368046T3 PL16859111.3T PL16859111T PL3368046T3 PL 3368046 T3 PL3368046 T3 PL 3368046T3 PL 16859111 T PL16859111 T PL 16859111T PL 3368046 T3 PL3368046 T3 PL 3368046T3
Authority
PL
Poland
Prior art keywords
behaviour
brain function
synthetic composition
modulating brain
modulating
Prior art date
Application number
PL16859111.3T
Other languages
English (en)
Inventor
Bruce Mcconnell
Emma ELISON
Louise Kristine VIGSNÆS
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL3368046T3 publication Critical patent/PL3368046T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
PL16859111.3T 2015-10-28 2016-10-28 Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania PL3368046T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201570696 2015-10-28
DKPA201670100 2016-02-24
PCT/DK2016/050344 WO2017071715A1 (en) 2015-10-28 2016-10-28 Synthetic composition and method for modulating brain function and behaviour

Publications (1)

Publication Number Publication Date
PL3368046T3 true PL3368046T3 (pl) 2022-11-28

Family

ID=58629784

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16859111.3T PL3368046T3 (pl) 2015-10-28 2016-10-28 Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania

Country Status (7)

Country Link
US (2) US10835545B2 (pl)
EP (1) EP3368046B1 (pl)
CN (1) CN108348535B (pl)
DK (1) DK3368046T3 (pl)
ES (1) ES2927009T3 (pl)
PL (1) PL3368046T3 (pl)
WO (1) WO2017071715A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3452051T3 (pl) * 2016-05-05 2022-11-14 Glycom A/S Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi
EP3458073B1 (en) * 2016-05-19 2023-10-25 Glycom A/S Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
WO2018207110A1 (en) * 2017-05-09 2018-11-15 Glycom A/S Synthetic composition for microbiota modulation
WO2018215960A1 (en) * 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising one or more human milk oligosaccharides (hmos)
EP3703698A4 (en) * 2017-11-02 2021-08-18 Glycom A/S ONE OR MORE HMOS TO REDUCE OR PREVENT FATIGUE AND / OR IMPROVE CONCENTRATION
KR20190130720A (ko) * 2018-05-15 2019-11-25 (주)에이피테크놀로지 2'-푸코실락토오스를 포함하는 뇌졸중 예방용 조성물
EP3897902B1 (en) * 2018-12-19 2023-09-13 Glycom A/S Separation of oligosaccharides
CA3164483A1 (en) * 2019-12-19 2021-06-24 Hill's Pet Nutrition, Inc. Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate
EP4255444A1 (en) * 2020-12-04 2023-10-11 Glycom A/S Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
WO2023237306A1 (en) 2022-06-09 2023-12-14 Dsm Ip Assets B.V. Nutritional composition comprising gos and hmos

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
RU2473695C2 (ru) 2006-03-09 2013-01-27 Сентр Насьональ Де Ля Решерш Сьентифик (Снрс) Способ получения сиалилированных олигосахаридов
CN102459295A (zh) 2009-04-07 2012-05-16 格礼卡姆股份公司 2’-o-岩藻糖基乳糖的合成
EP2451462B1 (en) * 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
ES2664828T3 (es) 2009-08-25 2018-04-23 Nestec S.A. Bifidobacterium longum y trastornos GI funcionales
DE202011111124U1 (de) 2010-02-19 2020-05-22 Glycom A/S Polymorph eines Tretrasaccharids, das N-Acetyllactosamin enthält
CA2805499A1 (en) 2010-07-16 2012-01-19 Glycom A/S Derivatization of oligosaccharides
CN103415297A (zh) 2010-12-29 2013-11-27 雀巢产品技术援助有限公司 用于减少压力相关肠症状的包含纤维和益生菌的营养组合物
CN103402376A (zh) 2010-12-31 2013-11-20 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
MY161034A (en) 2011-02-10 2017-04-14 Nestec Sa Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
CN103429604A (zh) 2011-02-21 2013-12-04 格礼卡姆股份公司 寡糖前体的混合物的组合物的催化氢解及其用途
CN103443113A (zh) 2011-03-18 2013-12-11 格力康公司 新型含岩藻糖的糖类衍生物的合成
EP2712362A4 (en) 2011-05-13 2014-12-24 Glycom As MANUFACTURE OF LACTO-N-TETRAOSE
MX349153B (es) * 2011-05-13 2017-07-14 Glycom As Diversificacion de oligosacaridos de leche humana (hmo) o precursores de los mismos.
CA2835986A1 (en) 2011-05-13 2012-11-22 Glycom A/S Method for generating human milk oligosaccharides (hmos) or precursors thereof
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN103958537A (zh) 2011-09-30 2014-07-30 格礼卡姆股份公司 Hmo核心结构的合成
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150065702A1 (en) 2012-03-20 2015-03-05 Glycom A/S Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof
MX2014012362A (es) 2012-04-13 2015-05-07 Trustees Boston College Composición prebiótica y métodos de uso.
WO2013161820A1 (ja) 2012-04-23 2013-10-31 国立大学法人京都大学 ビフィズス菌の増殖促進用組成物
EP2708147B1 (en) * 2012-09-14 2020-03-11 Abbott Laboratories Methods for increasing brain functionality using 2-fucosyl-lactose
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP2934189B1 (en) 2012-12-18 2019-11-06 Abbott Laboratories Human milk oligosaccharides to ameliorate symptoms of stress
CN104955344A (zh) 2012-12-18 2015-09-30 雅培制药有限公司 包含神经保护膳食寡糖的营养组合物
CA2904418A1 (en) 2013-03-12 2014-10-09 Nestec S.A. Assays and methods for selecting a treatment regimen for a subject with depression
EP3129030A1 (en) * 2014-04-08 2017-02-15 Abbott Laboratories Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
US20150305384A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US11040050B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040049B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US20160243139A1 (en) 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20160287637A1 (en) 2014-12-08 2016-10-06 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
WO2017071716A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
WO2017144062A1 (en) * 2016-02-24 2017-08-31 Glycom A/S Synthetic composition for microbiota modulation
EP3458073B1 (en) * 2016-05-19 2023-10-25 Glycom A/S Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
EP3589139A4 (en) * 2017-03-01 2020-12-23 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
WO2019111115A2 (en) * 2017-12-05 2019-06-13 Glycom A/S Human milk oligosaccharides for treating migraine

Also Published As

Publication number Publication date
CN108348535A (zh) 2018-07-31
US20180369260A1 (en) 2018-12-27
WO2017071715A1 (en) 2017-05-04
EP3368046A4 (en) 2019-07-03
US11684630B2 (en) 2023-06-27
CN108348535B (zh) 2021-08-31
EP3368046B1 (en) 2022-07-27
DK3368046T3 (da) 2022-10-31
ES2927009T3 (es) 2022-10-31
US20210077513A1 (en) 2021-03-18
US10835545B2 (en) 2020-11-17
EP3368046A1 (en) 2018-09-05

Similar Documents

Publication Publication Date Title
IL286669A (en) Compounds and methods for modulating tmprss6 expression
PL3368046T3 (pl) Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
IL285229A (en) Compounds and methods for modulating RNA function
IL252573A0 (en) Methods and systems for modulating nerves or other tissues
HK1258275A1 (zh) 用於調節血管緊張素原表達的化合物和方法
EP3349763A4 (en) SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION
IL271659A (en) Compositions and methods for modulating expression of complement factor B
EP3380000A4 (en) METHOD AND DEVICE FOR SUPPLYING THE BRAIN WITH IRRITATION
IL247389A0 (en) Methods and preparations for personal pain management
EP3368047A4 (en) SYNTHETIC COMPOSITION AND METHOD FOR MODULATING EMOTION AND MUTUAL DISORDERS
PT3353303T (pt) Composições e métodos para modulação da expressão de ataxina 3
GB201504222D0 (en) Droplet assemblies and methods for producing droplet assemblies
HK1254746A1 (zh) 睫毛膏組合物和方法
HK1254749A1 (zh) 睫毛膏組合物和方法
GB201520255D0 (en) Composition and method
HK1254747A1 (zh) 睫毛膏組合物和方法
HK1243646A1 (zh) 用於調節骨密度的方法
IL252191B (en) Compositions and methods for modulating at2r activity
HK1254750A1 (zh) 睫毛膏組合物和方法
HK1247088A1 (zh) 腦機能改善組合物
GB201509420D0 (en) Composition and method
GB201513492D0 (en) Method and composition
GB201401612D0 (en) Synthetic method
ZA201803467B (en) Management method
SI3534874T1 (sl) Kozmetični postopek